Clinical Trial Update: Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer [NA]

View source ↗

Summary

A completed study assessing the feasibility of using intratumoral washing fluid to detect EGFR mutations in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Pusan National University Hospital | Conditions: Non Small Cell Lung Cancer, EGFR Gene Mutation | NA | Status: COMPLETED